张玲钰,李修刚,王玉丽,刘钰强,谢亚非,高志刚,魏鹏,徐为人,汤立达,赵桂龙.化学通报,2015,78(7):638-643. |
3,6-二脱氧达格列净的合成及其降血糖活性研究 |
Synthesis and Hypoglycemic Activity of 3,6-Dideoxydapagliflozin |
投稿时间:2015-01-05 修订日期:2015-01-26 |
DOI: |
中文关键词: 关 键 词 SGLT2抑制剂 二脱氧 合成 降血糖活性 |
英文关键词:SGLT2 inhibitor, Dideoxy, Synthesis, Hypoglycemic activity |
基金项目:国家自然科学基金(21302141);天津市应用基础与前沿技术研究计划(14JCQNJC12900和14JCZDJC33500);铜仁学院博士启动基金(trxyDF1401) |
|
摘要点击次数: 3055 |
全文下载次数: 0 |
中文摘要: |
利用达格列净1作为原料经过两条路线合成了3,6-二脱氧达格列净9,其3,6-二脱氧的位置进一步经过了NOE技术确认,体外hSGLT2抑制试验和大鼠尿糖排泄试验表明3,6-二脱氧达格列净几乎没有SGLT2抑制活性,说明SGLT2抑制剂结构中葡萄糖片段上3-OH和6-OH同时脱除会导致SGLT2抑制剂完全丧失活性。 |
英文摘要: |
3,6-Dideoxydapagliflozin 9 was synthesized by two synthetic routes starting from dapagliflozin 1, whose 3,6-dideoxy functionality was further confirmed by NOE. In vitro inhibitory assay against hSGLT2 and rat urinary glucose excretion test found that 3,6-dideoxydapagliflozin 9 was almost completely inactive against hSGLT2, indicating that deletion of both 3-OH and 6-OH in the glucose moiety of SGLT2 inhibitors cannot be tolerated and would lead to complete loss of bioactivity. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|